Why Supply Chain and Value Analysis Can No Longer Operate Separately
There are some ideas in healthcare supply chain that become easier to see once you’ve worked enough projects.
One of them is this
Every cost savings initiative eventually becomes a healthcare value analysis initiative.
The only question is when.
For years, healthcare organizations have organized strategic sourcing and healthcare value analysis as though they were complementary but separate disciplines.
-
- Strategic sourcing identifies opportunities
- Healthcare value analysis evaluates products
- Strategic sourcing manages suppliers
Healthcare value analysis manages clinicians and stakeholders.
Strategic sourcing drives savings.
Healthcare value analysis protects quality and patient outcomes.
At least that is how we have traditionally described the work.
Operational reality increasingly suggests something different.
Because regardless of where a project begins, eventually the same pattern emerges.
-
- Contracts become clinicians
- Pricing becomes implementation
Savings models become stakeholder acceptance.
-
- Analytics become governance
Eventually, every cost savings initiative arrives at the same destination
Healthcare value analysis.
Standardization Is Rarely About Standardization
Consider product standardization.
At first glance, the opportunity appears relatively straightforward.
-
- Multiple products perform similar functions
- Variation exists
- Pricing opportunities exist
- Consolidation opportunities exist
A sourcing strategy is developed.
Savings projections are created.
Everything appears relatively simple.
Then the first physician asks a question.
“Are these products clinically equivalent?”
Suddenly the conversation changes.
-
- Clinical evidence is reviewed
End users become involved.
-
- Practice variation is discussed
Trials may become necessary.
-
- Education plans emerge
- Implementation plans are developed
- Communication strategies become necessary
The initiative that began as a sourcing opportunity has become a healthcare value analysis project.
The contract negotiation was never the difficult part.
The organizational change was.
SKU Rationalization Follows the Same Path
SKU rationalization often behaves in exactly the same way.
The opportunity begins with complexity.
Too many item numbers.
Too many substitutions.
Too many products performing essentially the same function.
Inventory carrying costs increase.
Supply chain complexity increases.
The opportunity appears obvious.
Until someone asks
“Who actually uses these products?”
Now the work changes.
-
- Clinical stakeholders become involved
- Operational workflows are reviewed
Storage implications are evaluated.
Inventory strategies are reconsidered.
-
- Conversion plans are developed
- Implementation timelines become important
Again, strategic sourcing identified the opportunity.
Healthcare value analysis determines whether the organization can successfully execute the change.
Vendor Consolidation Is Usually a Change Management Initiative Disguised as a Contract Negotiation
Vendor consolidation may be one of the clearest examples of this phenomenon.
The financial case often looks compelling.
-
- Fewer suppliers
- Greater leverage
- Improved pricing
Simplified contracting.
-
- Improved contract compliance
- Then implementation begins
- Departments have workflows
Physicians have preferences.
Service lines have historical relationships.
Training requirements emerge.
Clinical concerns emerge.
Operational implications emerge.
The project that originally appeared to be a supplier strategy discussion becomes a multidisciplinary change management initiative.
Once again
Healthcare value analysis.
Utilization Management Makes the Overlap Impossible to Ignore
Utilization initiatives may be where the overlap becomes most obvious.
Reducing unnecessary utilization initially sounds like a financial exercise.
Until organizations begin discussing
Clinical appropriateness.
-
- Practice variation
- Care pathways
- Physician autonomy
- Outcomes measurement
At that point, cost is no longer driving the conversation.
-
- Clinical evidence is
This is precisely where mature healthcare value analysis programs create value for organizations by providing a structured framework that balances financial stewardship, patient outcomes, clinician engagement, and operational realities. This balance has become one of the defining principles of modern healthcare value analysis practice.
The Invisible Line
Somewhere during every sourcing initiative an invisible line is crossed.
Before the line
-
- Pricing
- Contracts
- Suppliers
- Analytics
After the line
-
- Clinicians
- Implementation
- Governance
- Communication
- Accountability
Healthcare organizations often continue to view this transition as a handoff between departments.
It isn’t.
It is simply the next phase of the same initiative.
The organizations producing the strongest results understand this instinctively.
Their sourcing teams involve healthcare value analysis early.
Their healthcare value analysis teams involve sourcing early.
The work moves together because the work is connected.
The Workflows Tell the Story
Perhaps the strongest evidence comes from examining the workflows themselves.
Strategic sourcing initiatives move through opportunity identification, validation, stakeholder acceptance, implementation, and outcome measurement.
Healthcare value analysis initiatives move through intake, evidence gathering, stakeholder engagement, implementation, and monitoring.
Different names.
Remarkably similar work.
The overlap is not accidental.
Both disciplines are attempting to solve the same organizational challenge
How do we create change while protecting clinical quality, stakeholder trust, operational continuity, and financial stewardship?
Viewed through that lens, the distinction between strategic sourcing and healthcare value analysis becomes much smaller than many organizations believe.
Perhaps it always was.
The Question Organizations Should Be Asking
The question is no longer
“Should supply chain involve healthcare value analysis?”
Nor is it
“Should healthcare value analysis involve sourcing?”
The better question may be
Why are we still acting as though these are separate conversations?
Because regardless of whether an initiative begins with standardization, utilization management, supplier consolidation, SKU rationalization, clinical pathway alignment, or contract conversion, the destination remains remarkably consistent.
Strategic sourcing eventually requires healthcare value analysis.
Healthcare value analysis eventually requires strategic sourcing.
The organizations that recognize this reality earliest will almost certainly execute change more effectively than those that continue to operate as though the work exists in separate lanes.
Because it doesn’t.
It never really did.
The natural question that follows is equally important.
If every sourcing initiative eventually becomes healthcare value analysis work…
Does the reverse hold true?
The answer may be even more important than the question.
Because healthcare value analysis without strategic sourcing also has limits.
That is where our conversation continues next.
Discover the power of VAMS®—click the Request a Demo button below to get started.
Request a Demo